In stock
CBL 514 20mg
$130.00 AUD
CBL-514 is an investigational injectable compound being researched for targeted fat reduction. It is not a peptide. It was developed by Caliway Biopharmaceuticals and is designed to trigger the fat cells.
Important considerations
CBL-514 is still investigational; established fat-loss treatment.
